Indacaterol 300 µg

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)Healthy Volunteers

Phase 1

Cardiac Safety of Indacaterol

CompletedNCT01263808

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease, Healthy Volunteers

Start: 2008-04-30Updated: 2010-12-21

Phase 3

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00876694

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease (COPD)

Start: 2009-03-31End: 2010-10-31Updated: 2011-11-08